| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 03/04/2009 | EP2029673A2 Improved photostable fret-competent biarsenical-tetracysteine probes based on fluorinated fluoresceins |
| 03/04/2009 | EP2029644A1 Poly (vinyl alcohol) polymers, uses and preparation thereof |
| 03/04/2009 | EP2029626A2 Immune-derived moieties reactive against lysophosphatidic acid |
| 03/04/2009 | EP2029616A1 Chemical methods and apparatus |
| 03/04/2009 | EP1248797B1 Process for the separation of antithrombin-iii isoforms |
| 03/04/2009 | EP1064300B1 Peptide turn mimetics |
| 03/04/2009 | CN101379402A Method for cleavage of peptide bond at C-terminus of peptide, and method for determination of C-terminal amino acid sequence of peptide |
| 03/04/2009 | CN101379077A Small peptidic and peptido-mimetic affinity ligands for factor VIII and factor VIII-like proteins |
| 03/04/2009 | CN101379075A Synthesis of glucagon-like peptide |
| 03/04/2009 | CN101379074A Method for modifying peptide and method for identifying peptide |
| 03/04/2009 | CN101376672A BMP collagen frame extracting process |
| 03/04/2009 | CN100465285C An extracting method of carnosine |
| 03/04/2009 | CN100465270C Nereides protease, and a separating and purifying method and an application thereof |
| 03/03/2009 | US7498411 P49/STRAP is a novel protein involved in gene regulation and cell proliferation |
| 03/03/2009 | US7498410 Variant comprises a deactivated plasminogen activator inhibitor (PAI) binding site and a platelet integrin binding site within the tPA serine protease domain; anticoagulants; polynucleotides, vectors, and host cells; acute myocardial infarction, cardiovascular disorders; pharmacokinetics |
| 03/03/2009 | US7498407 Vascular endothelial cell growth inhibitor, VEGI-192a |
| 03/03/2009 | US7498406 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/03/2009 | US7498306 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/03/2009 | US7498154 Nucleotide sequences coding cytokine receptor for identifying modulators for prevention and treatment of infection, cell proliferative and autoimmune disorders |
| 03/03/2009 | US7498153 Chimeric immunogens |
| 03/03/2009 | US7498146 Containing high-molecular vWF multimers and being free from low-molecular vWF molecules and proteolytic vWF degradation products; chromatographic purification of Factor VIII or a Factor VIII/vWF-complex, admixing a purified high-molecular fraction of vWF molecules; hemophilia A, von Willebrand Disease |
| 03/03/2009 | US7498024 Expression vector comprising nucleotide sequences coding foot and mouth viral, as well as, immunoglobulin sequences for use in generation imunotherapeutics |
| 03/03/2009 | US7497950 Flat regenerated cellulose or polyether sulfone membranes of substantially the same molecular weightare stacked together; by employing membranes in series without any gaskets or spacers in-between, ultrafiltration is carried out to separate two proteins relatively close in molecular weight or size |
| 02/26/2009 | WO2009026524A1 Delipidation of hdl using serum opacity factor to prevent atherosclerosis |
| 02/26/2009 | WO2009026393A2 Amino acid substituted molecules |
| 02/26/2009 | WO2009025754A2 Methods for purification of alpha-1-antitrypsin and apolipoprotein a-i |
| 02/26/2009 | WO2009025543A2 A method to produce palm based polypeptides |
| 02/26/2009 | WO2009024726A2 Method for purifying or detecting a target protein |
| 02/26/2009 | WO2009024620A2 A process for isolation and purification of a target protein free of prion protein (prpsc) |
| 02/26/2009 | WO2008156729A3 Vaccines against chlamydia infection |
| 02/26/2009 | WO2008106043A3 Ultra-fast chromatography |
| 02/26/2009 | WO2008099285A3 Control of transport properties to and from nanoparticle surfaces |
| 02/26/2009 | US20090054632 Hydrophobically-modified protein compositions and methods |
| 02/26/2009 | US20090054628 Method and system for in vitro protein folding |
| 02/26/2009 | US20090054627 Process for the purification of il-18 binding protein |
| 02/26/2009 | US20090054626 Crustacean-derived protein having antifreeze activity |
| 02/26/2009 | US20090054625 Recombinant protein variants |
| 02/26/2009 | US20090054624 useful in the treatment of a condition which is responsive to the PRO polypeptide, an agonist or antagonist thereof or an anti-PRO antibody |
| 02/26/2009 | US20090054605 including a head assembly having an array of nozzles each coupled to a reservoir of liquid reagent and a base assembly having an array of reaction wells |
| 02/26/2009 | US20090054459 Substituted indoles |
| 02/26/2009 | US20090054419 3,7-diamino-10h-phenothiazine salts and their use |
| 02/26/2009 | US20090054332 Thombopoietin peptide conjugates |
| 02/26/2009 | US20090054322 Polypeptides and compositions comprising same and methods of using same for treating cxcr4 associated medical conditions |
| 02/26/2009 | US20090054320 Vesiculins |
| 02/26/2009 | US20090054246 Virus-like platform for rapid vaccine discovery |
| 02/26/2009 | US20090053247 Biological materials and uses thereof |
| 02/26/2009 | CA2707840A1 Amino acid substituted molecules |
| 02/26/2009 | CA2696865A1 A process for isolation and purification of a target protein free of prion protein (prpsc) |
| 02/26/2009 | CA2696363A1 Method for purifying or detecting a target protein |
| 02/26/2009 | CA2694854A1 Methods for purification of alpha-1-antitrypsin and apolipoprotein a-i |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2028186A2 Hepatitis C inhibitor tri-peptides |
| 02/25/2009 | EP2027875A1 A Process for Isolation and Purification of a Target Protein free of Prion Protein (PrPSC) |
| 02/25/2009 | EP2027145A1 A process for the preparation of poly-alfa-glutamic acid and derivatives thereof |
| 02/25/2009 | EP2026892A2 Methods for reducing or preventing liquid-liquid phase separation in high concentration protein salutions |
| 02/25/2009 | EP1794181A4 Methods and materials for optimization of electronic transportation and hybridization reactions |
| 02/25/2009 | EP0906448B1 Methods for the diagnosis and prognosis of cancer |
| 02/25/2009 | EP0815141B2 Antibodies active against a fusion polypeptide comprising a histidine portion |
| 02/25/2009 | CN101374955A Targeting vector-phospholipid conjugates |
| 02/25/2009 | CN101374855A Purification and use of a factor for supporting wound healing |
| 02/25/2009 | CN101372705A Preparation of recombinant long-acting glucagon peptide analogue |
| 02/25/2009 | CN101372506A Novel process for preparing eptifibatide by purification |
| 02/25/2009 | CN101372505A Method for preparing desmopressin acetate |
| 02/25/2009 | CN101372504A Method for purifying desmopressin |
| 02/25/2009 | CN101372503A Method for extracting keratin from feather |
| 02/25/2009 | CN101372502A Separating and extracting method of Bacillus subtilis lipopeptide antibiotic substance |
| 02/25/2009 | CN101372501A Preparation of soy protein isolate |
| 02/25/2009 | CN101372500A Extracting method and use of Torulopsis capsulatus allergen |
| 02/25/2009 | CN100463921C Albumin purifaction |
| 02/25/2009 | CN100463919C Extracellular antiseptic protein for Bacillus subtilis and its separation and purification method |
| 02/25/2009 | CN100463917C Reductive alkylation of glycopeptide antibiotics |
| 02/25/2009 | CN100463682C Egg white activity extraction extracting and activity measuring technique |
| 02/24/2009 | US7495082 Antibodies to PRO4349 polypeptides |
| 02/24/2009 | US7495076 Methods of increasing bone density/preventing osteoporosis, of reducing joint pain and/or joint deterioration from osteoarthritis, degenerative joint disease, joint defect, and rheumatoid arthritis; maximum and consistent bioavailability |
| 02/24/2009 | US7495072 Process for preparation of mixtures of polypeptides using purified hydrobromic acid |
| 02/24/2009 | US7495069 FRET protease assays for botulinum serotype A/E toxins |
| 02/24/2009 | US7494975 A polyanion selected from a heparin, a dextran, a pentosan, resobene, curdian sulfate, or 2-naphthalene sulfonate polymer and a CD4 polypeptide with a beta-hairpin confirmation; blocking HIV interaction with coreceptors |
| 02/24/2009 | US7494969 a plant-derived protein with anti-cancer properties which binds the human growth hormone-releasing hormone (hGHRH). Said protein, which is obtained from the Pilocarpus Heterophyllus plant, is particularly adapted for preparing a medicament that is intended for the treatment of cancers for which growth |
| 02/24/2009 | US7494820 Competitive binding; for detection of pharmaceuticals, metabolites, and microorganisms; qualitative/quantitative analysis |
| 02/24/2009 | US7494810 Method for accessing microbial diversity |
| 02/24/2009 | US7494797 Recombinant terminal deoxynucleotidyl transferase with improved functionality |
| 02/24/2009 | US7494794 Derived from filamentous fungus belonging to genus Penicillium; improved heat resistance and substrate specificity |
| 02/24/2009 | US7494654 Compositions and methods for treating cardiovascular conditions with botulinum toxin |
| 02/24/2009 | US7494577 Tandem isotachophoresis/zone electrophoresis method and system |
| 02/24/2009 | CA2247820C Functionalized nanotubes |
| 02/24/2009 | CA2214633C Antibody purification by low-ph hydrophobic interaction chromatography |
| 02/19/2009 | WO2009023047A2 Methods for the directed expansion of epitopes for use as antibody ligands |
| 02/19/2009 | WO2009022900A2 A process to produce polypeptides from soybean |
| 02/19/2009 | WO2009002832A3 Inhibitors of ncca-atp channels for therapy |
| 02/19/2009 | WO2008066816A3 Derivatization or ligaton of peptides |
| 02/19/2009 | WO2006052914A3 Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 02/19/2009 | US20090048433 Scalable Process for Protein Purification |
| 02/19/2009 | US20090048430 Site specific protein modification |
| 02/19/2009 | US20090048429 aspartic acid aldehyde moieties via reduction, deprotecting, reacting with benzyloxycarbonyl-tert-leucine under coupling conditions, deprotection conditions to provide amine and reacting amine and 4-amino-3-chlorobenzoic; for preparing caspase inhibitors and/or prodrugs |
| 02/19/2009 | US20090048122 Stabilized polypeptide compositions |
| 02/19/2009 | US20090047681 Entropic trapping and sieving of molecules |
| 02/19/2009 | US20090047387 Protease variants |
| 02/19/2009 | US20090047251 Conjugates of hydroxyalkyl starch and a protein |
| 02/19/2009 | US20090045057 provide a technology which makes it possible to stably maintain a sample that contains protein under electrophoresis in a liquid state, to enable immediate freeze-drying of the sample after electrophoresis and then to stably maintain the sample in a dried state |
| 02/19/2009 | CA2686817A1 Methods for the directed expansion of epitopes for use as antibody ligands |